Male contraceptive gel passes animal testing

An experimental new type of male contraceptive, Vasagel, that works by blocking sperm flow with a gel has been successful in monkey trials.

The results of a two-year trial was published in Basic and Clinical Andrology and showed the gel works and is safe in primates. The experimental contraceptive is administered as an injection, under anaesthetic and acts as a long-term contraception.

Allan Pacey, professor of andrology at the University of Sheffield, said: "The study shows that, in adult male monkeys at least, the gel is an effective form of contraception.

"But in order for it to have a chance of replacing the traditional surgical method of vasectomy, the authors need to show that the procedure is reversible. The idea of a social venture company to develop the idea is intriguing.

"I would imagine there is a worldwide market for a new male contraceptive, but trials in humans and more long-term safety data are required before we will know if it is a success."

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho